PropertyValue
?:abstract
  • BACKGROUND Prior studies have shown the presence of immunohistochemical staining for the SARS-CoV-2 spike protein (SP) in endothelial cells and eccrine epithelium of acral perniosis classified as \'COVID toes\'. Yet, other studies have been unable to detect SARS-CoV-2 RNA in skin biopsies of \'COVID toes\' by reverse-transcriptase polymerase chain reaction testing. OBJECTIVE In order to address these apparently conflicting findings, we compared detection of SARS-CoV-2 SP, through RNA in situ hybridization (ISH) vs immunohistochemistry (IHC), in skin biopsies of acral perniotic lesions presenting during the COVID-19 pandemic. RESULTS Three of six cases showed positive immunohistochemical labeling of endothelial cells, with 1 of 3 cases with sufficient depth also having labeling of eccrine glands, using an anti-SP SARS-CoV-2 antibody. These three cases positive with IHC were negative for SP by RNA ISH. CONCLUSION While the gold standard for detection of SARS-CoV-2 in tissue sections has yet to be determined, the detection of SARS-CoV-2 SP alone without spike RNA suggests cleaved SP may be present in cutaneous endothelial cells and eccrine epithelium, providing a potential pathogenetic mechanism of COVID-19 endotheliitis. This article is protected by copyright. All rights reserved.
?:creator
?:doi
  • 10.1111/cup.13866
?:doi
?:journal
  • Journal_of_cutaneous_pathology
?:license
  • unk
?:pmid
?:pmid
  • 32895985
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein.
?:type
?:year
  • 2020-09-07

Metadata

Anon_0  
expand all